Literature DB >> 11468249

Heterozygous M3Mmalton alpha1-antitrypsin deficiency associated with end-stage liver disease: case report and review.

V Canva1, S Piotte, J P Aubert, N Porchet, M Lecomte-Houcke, G Huet, T Zenjari, D Roumilhac, F R Pruvot, P Degand, J C Paris, M Balduyck.   

Abstract

Alpha1-antitrypsin (alpha1AT) deficiency is an autosomal recessive disorder that can cause pulmonary emphysema and liver disease. We report here the case of a 59-year-old woman who was admitted to hospital for evaluation of jaundice. She had no history of hepatitis or childhood liver disease. She had never received a blood transfusion, nor had she abused drugs or alcohol. Transjugular liver biopsy was then performed and revealed a micronodular cirrhosis. Ten months later, because of persistent liver cell failure and ascites, she underwent an orthotopic liver transplantation. Investigation of alpha1AT system in the proband revealed a substantial decrease in serum alpha1AT associated with a low elastase inhibitory capacity. The Pi phenotype revealed a PiM-like profile. Sequencing of exons 1-5 demonstrated the presence of the M3 allele. Moreover, a triple nucleotide deletion was detected in exon 2 of one allele. This caused an "in-phase" frameshift, coding for a protein deficient in a single Phe residue, which corresponded to the Mmalton variant. After liver biopsy, periodic acid-Schiff-positive acidophilic bodies resistant to diastase digestion were observed in the cytoplasm of hepatocytes. These results demonstrated that our patient had a heterozygous M3Mmalton alpha1AT genotype related to a deficiency phenotype. This observation is the first of a patient with heterozygous Mmalton genotype associated with an alpha1AT deficiency that induced severe liver disease requiring orthotopic liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468249

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.

Authors:  Aleksandra Topic; Mila Ljujic; Dragica Radojkovic
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

Review 2.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

3.  The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency Variant.

Authors:  Riccardo Ronzoni; Ilaria Ferrarotti; Emanuela D'Acunto; Alice M Balderacchi; Stefania Ottaviani; David A Lomas; James A Irving; Elena Miranda; Annamaria Fra
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

4.  Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.

Authors:  Philippe Joly; Olivier Guillaud; Valérie Hervieu; Alain Francina; Jean-François Mornex; Colette Chapuis-Cellier
Journal:  Orphanet J Rare Dis       Date:  2015-10-07       Impact factor: 4.123

5.  Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection.

Authors:  T Motawi; O G Shaker; R M Hussein; M Houssen
Journal:  Balkan J Med Genet       Date:  2017-03-09       Impact factor: 0.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.